2,162
Participants
Start Date
August 12, 2022
Primary Completion Date
May 25, 2023
Study Completion Date
May 25, 2023
V116
Pneumococcal 21-valent conjugate vaccine with 4 μg of each of the following pneumococcal polysaccharides (PnPs) antigen: 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15C, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, and 35B in each 0.5 mL sterile solution
PPSV23
Pneumococcal 23-valent conjugate vaccine with 25 μg of each of the following PnPs antigen: 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F in each 0.5 mL sterile solution
Tropeninstitut Wien 1060 ( Site 0300), Vienna
Medizinische Universität Wien ( Site 0302), Vienna
Sanos Clinic-Sanos Clinic ( Site 0402), Herlev
Danske Lægers Vaccinations Service - Søborg ( Site 0404), Søborg
Medizinische Universitaet Innsbruck ( Site 0301), Innsbruck
Sanos Clinic - Syddanmark ( Site 0400), Vejle
Danske Lægers Vaccinations Service - Århus ( Site 0403), Aarhus
Medizinische Universität Graz-Klinische Abteilung für Pulmonologie ( Site 0304), Graz
Sanos Clinic - Nordjylland ( Site 0401), Aalborg
Rochester Clinical Research, Inc. ( Site 0033), Rochester
FVR, Turun rokotetutkimusklinikka ( Site 0500), Turku
Charlottesville Medical Research ( Site 0013), Charlottesville
Health Research of Hampton Roads, Inc. ( Site 0002), Newport News
M3 Wake Research Associates ( Site 0035), Raleigh
Hospital La Princesa-Clinical Pharmacology ( Site 0815), Madrid
FVR, Porin rokotetutkimusklinikka ( Site 0508), Pori
HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-Respiratory ( Site 0808), Pozuelo de Alarcón
Velocity Clinical Research, Greenville ( Site 0021), Greenville
Headlands Research Orlando ( Site 0017), Orlando
Indago Research & Health Center, Inc ( Site 0011), Hialeah
L&C Professional Medical Research Institute ( Site 0012), Miami
Clinical Research Trials of Florida ( Site 0001), Tampa
Clinical Research Associates Inc ( Site 0039), Nashville
Kentucky Pediatric/ Adult Research ( Site 0036), Bardstown
Fundación Oftalmologica del Mediterraneo-Vaccine Research ( Site 0818), Valencia
FVR, Seinäjoen rokotetutkimusklinikka ( Site 0504), Seinäjoki
Healthcare Research Network - Chicago ( Site 0006), Flossmoor
Alliance for Multispecialty Research, LLC ( Site 0031), Kansas City
Methodist Physicians Clinic/CCT Research ( Site 0029), Fremont
Maccabi Healthcare Services ( Site 0606), Jerusalem
Baptist Health Center For Clinical Research ( Site 0015), Little Rock
Lynn Health Science Institute ( Site 0014), Oklahoma City
DCOL Center for Clinical Research ( Site 0025), Longview
Dynamed Clinical Research, LP d/b/a DM Clinical Research ( Site 0016), Tomball
IMA Clinical Research San Antonio ( Site 0020), San Antonio
Lynn Institute of Denver ( Site 0003), Aurora
Clinical Research Prime Rexburg ( Site 0040), Rexburg
Desert Clinical Research/ CCT Research ( Site 0019), Mesa
Fiel Family and Sports Medicine, PC/CCT Research ( Site 0008), Tempe
Axces Research ( Site 0034), Santa Fe
Healor Primary Care / CCT Research ( Site 0028), Las Vegas
FVR, Oulun rokotetutkimusklinikka ( Site 0501), Oulu
Valley Clinical Trials, Inc. ( Site 0023), Northridge
Artemis Institute for Clinical Research ( Site 0027), San Diego
Millennium Clinical Trials ( Site 0004), Simi Valley
Diablo Clinical Research, Inc. ( Site 0022), Walnut Creek
Clalit Health Services - Sakhnin Community Clinic-Research Unit ( Site 0602), Sakhnin
Rambam Health Care Campus ( Site 0603), Haifa
Meir Medical Center ( Site 0601), Kfar Saba
Sheba Medical Center-Early Phase Clinical Trials Unit ( Site 0604), Ramat Gan
Hadassah Medical Center ( Site 0600), Jerusalem
Velocity Clinical Research, Providence ( Site 0018), East Greenwich
Colchester Research Group ( Site 0202), Truro
Hamilton Medical Research Group ( Site 0208), Hamilton
Milestone Research Inc. ( Site 0201), London
Manna Research Toronto ( Site 0209), Toronto
Manna Research Mirabel ( Site 0207), Mirabel
Manna Research Montreal ( Site 0203), Pointe-Claire
Q&T Research Sherbrooke Inc. ( Site 0204), Sherbrooke
Diex Recherche Trois-Rivieres ( Site 0206), Trois-Rivières
FVR, Espoon rokotetutkimusklinikka ( Site 0509), Espoo
FVR, Etelä-Helsingin rokotetutkimusklinikka ( Site 0503), Helsinki
Helsinki East Vaccine Research Clinic ( Site 0502), Helsinki
IN VIVO ( Site 0711), Bydgoszcz
Centrum Medyczne Pratia Bydgoszcz-Centrum Medyczne Pratia Bydgoszcz ( Site 0709), Bydgoszcz
MICS Centrum Medyczne Torun ( Site 0706), Torun
Alergotest s.c Specjalistyczne Centrum Medyczne ( Site 0703), Lublin
Centrum Medyczne Medyk ( Site 0704), Rzeszów
Clinmedica OMC ( Site 0701), Skierniewice
EBA CENTELLES ( Site 0800), Centelles
Centre d'Atenció Primària Vallcarca - Sant Gervasi ( Site 0801), Barcelona
EAP Sardenya ( Site 0802), Barcelona
Merck Sharp & Dohme LLC
INDUSTRY